Phase III, Multicentre, Randomised Study of Fludarabine/Cyclophosphamide Combination With or Without Rituximab in Patients With Untreated Mantle Cell Lymphoma
Phase of Trial: Phase II/III
Latest Information Update: 09 Nov 2018
At a glance
- Drugs Cyclophosphamide (Primary) ; Cyclophosphamide (Primary) ; Fludarabine (Primary) ; Fludarabine (Primary) ; Rituximab
- Indications Mantle-cell lymphoma
- Focus Therapeutic Use
- 29 Oct 2018 Status changed from active, no longer recruiting to completed.
- 31 Aug 2018 Biomarkers information updated
- 04 May 2012 Status changed from recruiting to active, no longer recruiting as reported by United Kingdom Clinical Research Network.